Status:
COMPLETED
Investigation of the Naída CI M90 Sound Processor in Various Acoustic Scenarios
Lead Sponsor:
Advanced Bionics AG
Conditions:
Cochlear Hearing Loss
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
In this clinical trial, an un-controlled, repeated measures open design with within-subject comparison will be used to evaluate the effect of Naída Link M90 hearing aid and Naída CI M90 sound processo...
Eligibility Criteria
Inclusion
- CI users with a CII, HiRes90K (Advantage) or HiRes Ultra implant system
- Bilateral users: two implant systems
- Bimodal users: hearing aid contralateral
- Minimum of 18 years of age
- Minimum of six months experience with their implant system
- Minimum of six months experience with the Naída CI Q-Series sound processor
- Ability to give feedback on sound quality
- Speech intelligibility with the HSM sentence test in noise at 10 dB SNR \> 10% as obtained during previous visits in the clinical routine
- Fluent in German language
Exclusion
- Difficulties additional to hearing impairment that would interfere with the study procedures
- Concurrent participation in other study
- Pregnant and breast-feeding women
Key Trial Info
Start Date :
November 20 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 9 2021
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04815343
Start Date
November 20 2020
End Date
August 9 2021
Last Update
November 24 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medizinische Hochschule Hannover (MHH)
Hanover, Lower Saxony, Germany, 30625